Company Overview and News

With two acquisitions, Borosil targets 40% growth

2016-08-01 thehindubusinessline
After making two successive acquisitions this year, Borosil Glass Works is planning to grow at 40 per cent this fiscal, targeting a turnover of ₹560 crore.

Borosil acquires 60.3% stake in Klasspack

2016-08-01 thehindubusinessline
Borosil Glass Works has acquired 60.3 per cent stake in Nashik-based Klasspack, a glass packaging firm, for an undisclosed amount.

Top Buzzers: Borosil Glass Works, CG Consumer, Fortune Financial

2016-08-01 moneycontrol
Shares of Crompton Greaves Consumer Electrical (demerged arm of Crompton Greaves) rose 12 percent intraday on the back of robust first quarter numbers (April-June).

Borosil Glass Works soars 7% on investment in wholly owned arm

2016-03-22 moneycontrol
"Borosil has made an investment of Rs 22.00 crore by way of subscription in 6 percent optionally convertible non-cumulative redeemable preference shares in Hopewell Tableware, its unlisted wholly owned subsidiary," says the company in its filing.

Bharti Airtel in focus after entering into tower sale pact with American Tower Corp

2016-03-22 indiainfoline
We encourage visitors to register on IIFL. Registering on the site is absolutely Free and offers you the following benefits.

Borosil Glass Works invests Rs 22 crore in subsidairy

2016-03-21 indiainfoline
We encourage visitors to register on IIFL. Registering on the site is absolutely Free and offers you the following benefits.

Volumes jump at Max India counter

2016-02-18 indiainfoline
Borosil Glass Works, Container Corporation of India, Media Matrix Worldwide and Aban Offshore are among the other stocks to see a surge in volumes on BSE today, 18 February 2016.

Volumes jump at Media Matrix Worldwide counter

2016-02-16 indiainfoline
Shilpa Medicare, Borosil Glass Works, Maruti Suzuki India and Strides Shasun are among the other stocks to see a surge in volumes on BSE today, 16 February 2016.

Stocks in news: Jet, Tata Power, Info Edge, PTC India, Sobha

2016-02-08 moneycontrol
DLF | Jaiprakash Associates | TVS Tyres | Jet Airways | Tata Power | Indo Count | PC Jeweller | Cummins | KPIT Technologies | Rallis India | Glenmark | Info Edge | Jamna Auto | Borosil Glass Works | Vakrangee | AstraZeneca | McDowell Holdings | PTC India | Claris Life and Sobha are stocks, which are in the news today...

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...